Figure 3C (Supplementary Fig. 2C) shows that cancer cells treated with combination of methyl gallate and low dose oxaliplatin (i.e. 10 μM) displayed an overall significant induction of CD112, CD155, ULBP-1, ULBP-2, ULBP-3, DR4, and DR5 (p < 0.05, p < 0.01). This evidence concerns the gene TNFRSF10A and cancer.